PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules

Immunotherapy targeting programmed cell death‐1 (PD‐1) has considerably improved the prognosis of patients with advanced cancers; however, its efficacy in the treatment of pancreatic ductal adenocarcinoma (PDAC) is unfavourable. To address the issue of PDAC immunotherapy, we investigated the express...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yue, Chen, Xianlong, Mo, Shengwei, Ma, Heng, Lu, Zhaohui, Yu, Shuangni, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977274/
https://www.ncbi.nlm.nih.gov/pubmed/35037417
http://dx.doi.org/10.1002/cjp2.259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977274/
https://www.ncbi.nlm.nih.gov/pubmed/35037417
http://dx.doi.org/10.1002/cjp2.259

Ejemplares similares